From: Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population
Total time of use (minutes)
Number of subjects (percentage)*
0
48 (4,46%)
1 to 20
58 (5,39%)
21 to 40
46 (4,27%)
41 to 60
53 (4,92%)
60 to 100
78 (7,24%)
100 to 200
174 (16,16%)
200 to 400
189 (17,55%)
> 400
431 (40.02%)